ImmunoConcEpT - UMR 5164: Dépôts récents
Voici les éléments 81-100 de 319
-
Model for predicting age-dependent safety and immunomodulatory effects of STING ligands in non-human primates
(Molecular Therapy Methods and Clinical Development. vol. 28, pp. 99-115, 2023)Article de revueLibre accès -
Characterization of the novel HLA-DPB1*11:01:06 allele by sequencing-based typing
(HLA. vol. 101, n° 3, pp. 311-312, 2023)Article de revueLibre accès -
Characterization of the novel HLA-DPA1*02:01:21 allele by sequencing-based typing
(HLA. vol. 101, n° 3, pp. 309-311, 2023)Article de revueLibre accès -
Characterization of the novel HLA-DPB1*1348:01 allele by sequencing-based typing
(HLA. vol. 101, n° 3, pp. 313-314, 2023)Article de revueLibre accès -
Characterization of the novel HLA-B*15:01:01:65Q allele by sequencing-based typing
(HLA. vol. 101, n° 3, pp. 280-281, 2023)Article de revue -
Characterization of the novel HLA-B*08:302 allele by sequencing-based typing
(HLA. vol. 101, n° 3, pp. 278-280, 2023)Article de revueLibre accès -
Characterization of the novel HLA-DQA1*05:05:14 allele by sequencing-based typing
(HLA. vol. 101, n° 3, pp. 299-300, 2023)Article de revueLibre accès -
Cytomegalovirus DNAemia Requiring (Val)Ganciclovir Treatment for More Than 8 Weeks Is a Key Factor in the Development of Antiviral Drug Resistance
(Open Forum Infectious Diseases. vol. 10, n° 2, 2023)Article de revueLibre accès -
A Patient with Lymphadenopathy, Hypercalcemia, and Kidney Injury
(Kidney360. vol. 4, n° 9, pp. E1341-E1342, 2023)Article de revueLibre accès -
Characterization of the novel HLA-DQA1*02:01:14 allele by sequencing-based typing
(HLA. vol. 101, n° 3, pp. 298-299, 2023)Article de revueLibre accès -
Comparing COVID-19 disease severity in patients with rheumatic and inflammatory diseases between the first and the subsequent waves
(Joint Bone Spine. vol. 90, n° 5, 2023)Article de revueLibre accès -
Immune response to the recombinant herpes zoster vaccine in people living with HIV over 50 years of age compared to non-HIV age-/gender-matched controls (SHINGR'HIV): a multicenter, international, non-randomized clinical trial study protocol
(BMC Infectious Diseases. vol. 24, n° 1, pp. 329, 2024-03-19)Article de revueLibre accès -
Impact of house dust mite in vitiligo skin: environmental contribution to increased cutaneous immunity and melanocyte detachment
(British Journal of Dermatology. vol. 189, n° 3, pp. 312-327, 2023-05)Article de revue -
Antiplatelet and anticoagulant therapies in hereditary hemorrhagic telangiectasia: A large French cohort study (RETROPLACO℡)
(Thrombosis Research. vol. 229, pp. 107-113, 2023-07)Article de revue -
Safety profile of upadacitinib in patients at risk of cardiovascular disease: Integrated post hoc analysis of the SELECT phase III rheumatoid arthritis clinical programme
(Annals of the Rheumatic Diseases. vol. 82, n° 9, pp. 1130-1141, 2023)Article de revueLibre accès -
Characterization of the novel HLA-DPB1*1463:01N allele by sequencing-based typing
(HLA. vol. 102, n° 3, pp. 393-395, 2023-06)Article de revueLibre accès -
Isolated IgG4-related cholecystitis mimicking an advanced gallbladder cancer: Don't fall into the trap
(Digestive and Liver Disease. vol. 55, n° 9, pp. 1297-1298, 2023-06)Article de revue -
Characterization of the novel HLA-DQA1*01:64:02 allele by sequencing-based typing
(HLA. vol. 102, n° 3, pp. 380-381, 2023)Article de revue -
Microbial gasdermins: More than a billion years of pyroptotic-like cell death
(Seminars in Immunology. vol. 69, 2023)Article de revueLibre accès -
Recommendations for assessing the risk of cardiovascular disease and venous thromboembolism before the initiation of targeted therapies for chronic inflammatory rheumatic diseases
(Joint Bone Spine. vol. 90, n° 5, 2023-05)Article de revueLibre accès